美国甲状腺癌差异与社会脆弱性的关联
基于CDC社会脆弱性指数与SEER患者数据库,回顾性评估1975至2017年199340例成人甲状腺癌患者。随总体社会脆弱性升高,各亚型随访月数、生存率下降,晚期分期比值比升高,手术、放疗、化疗等治疗几率下降。
要点
- 随总体社会脆弱性升高,甲状腺乳头状癌、滤泡状癌、髓样癌、嗜酸细胞癌和未分化癌患者随访月数均减少(p=0.001)。
- 最低与最高脆弱性队列比较,随访月数相对下降从未分化癌的55.6%(14.5至6.5个月)到嗜酸细胞癌的17%(108.6至90.2个月)。
- 社会经济地位脆弱性、家庭构成与住房-交通类型脆弱性对上述总体趋势贡献较大。
核心结论
- 研究显示,在美国,随着总体社会脆弱性升高,甲状腺癌诊疗与预后出现显著不良变化,并识别出哪些健康社会决定因素在相互关联的真实世界情境中对差异的量化贡献更大。
研究设计与样本
- 回顾性队列研究,纳入1975至2017年美国199340例成人甲状腺癌患者,使用CDC社会脆弱性指数与SEER患者数据库,评估随访/监测月数、生存、晚期分期和治疗接受的回归趋势,并分析15项健康社会决定因素变量,同时考虑社会人口学地区差异。
主要发现
- 随总体社会脆弱性升高,甲状腺乳头状癌、滤泡状癌、髓样癌、嗜酸细胞癌和未分化癌患者随访月数减少(p=0.001)。
- 最低与最高脆弱性队列比较,随访月数相对下降从未分化癌的55.6%(14.5至6.5个月)到嗜酸细胞癌的17%(108.6至90.2个月)。
- 所有甲状腺癌患者均出现生存下降,从未分化癌的55.9%(9.6至4.2)到嗜酸细胞癌的28.3%(97至69.5)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: As thyroid cancer incidence rises, it is increasingly valuable to recognize disparities in treatment and diagnosis. Prior investigations into social determinants of health (SDoH) are limited to pediatric populations or studies looking at single factors such as race or environmental influences. Utilizing the CDC-social vulnerability index and SEER-patient database to assess the amalgamated, real-world influence of varied SDoH and their quantifiable impact on thyroid cancer disparities across the United States. Methods: In a retrospective cohort study, 199,340 adult thyroid cancer patients from 1975 to 2017 were assessed for significant regression trends in months of follow-up/surveillance, survival, late staging, and treatment receipt across thyroid cancer-subtypes with increasing overall social vulnerability, as well as in 15 SDoH variables regarding socioeconomic status, minority-language status, household composition, and housing-transportation across all the U.S. counties while accounting for sociodemographic regional differences. Results: With increasing overall social vulnerability, decreases in months of follow-up were observed with patients with papillary, follicular, medullary, oncocytic, and anaplastic thyroid cancer (p = 0.001). Comparing lowest with highest vulnerability cohorts, relative decreases in months of surveillance ranged from 55.6% (14.5-6.5 months) with anaplastic to 17% (108.6-90.2) with oncocytic. Socioeconomic status vulnerabilities, followed by vulnerabilities in household composition and housing-transportation type, contributed to these overall trends. Similar survival decreases occurred across all thyroid cancer patients, ranging from 55.9% (9.6-4.2) with anaplastic to 28.3% (97-69.5) with oncocytic. Minority-language status vulnerabilities and housing-transportation types largely contributed to these trends. Increasing overall vulnerability was associated with increased odds of advanced staging for papillary (odds ratio [OR] = 1.07 [confidence interval, CI 1.03-1.12]) and decreased odds of indicated treatment via surgery (lowest, medullary: 0.91 [CI 0.84-0.99]), radiation therapy (lowest, anaplastic: 0.88 [CI 0.82-0.93]), and chemotherapy (lowest, oncocytic: 0.81 [CI 0.67-0.98]) were observed. Vulnerabilities in minority-language status and housing-transportation, followed by socioeconomic status vulnerabilities, were differential contributors to these overall vulnerability trends. Conclusions: Our results show significant detriments in thyroid cancer care and prognosis in the United States with increasing overall social vulnerability while identifying which SDoH quantifiably contribute more to disparities in inter-relational, real-world-like contexts.
引用
- Fei-Zhang DJ, Verma R, Arimoto R, et al. Social Vulnerability Association with Thyroid Cancer Disparities in the United States. Thyroid. 2024. PMID: 38069566. doi:10.1089/thy.2023.0370
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。